Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The independent source for health policy research, polling, and news.
1,861 - 1,880 of 3,969 Results
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Groupon and other deal sites are the latest marketing tactic in medicine, offering bargain prices but potentially unnecessary, duplicative services.
KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.
It’s easy to criticize pharmaceutical and insurance companies. But we spend much more on hospitals.
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
A proposed state law would require on-campus health centers to provide students with the medicines that allow them to end an unwanted pregnancy. Former Gov. Jerry Brown vetoed a similar bill last year, but Gov. Gavin Newsom has said he would sign it.
In Colorado case, the right to aid a cancer patient’s death runs up against faith-based hospital policies. As more states have passed laws, about 1 in 6 acute care beds nationally is in a hospital that is Catholic-owned or -affiliated.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Patients are often told to be smart consumers and shop around for health care before they use it. What happens when people actually take that advice?
Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Wyoming is taking on expensive air ambulance bills by trying to expand Medicaid to cover transport for all patients. This is a big change: a red state seeking to control what's been a growing free-market bonanza.
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Dialysis companies are fighting a bill in the California legislature that could disrupt their business model. Their weapons: campaign cash and a sophisticated public relations campaign.
© 2026 KFF